$6.88 Billion is the total value of Perceptive Advisors's 139 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 41.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MRTX | Sell | MIRATI THERAPEUTICS INC | $599,326,000 | -41.8% | 3,387,745 | -46.8% | 8.71% | +30.2% |
| Sell | TRAVERE THERAPEUTICS INCnote 2.500% 9/1 | $454,824,000 | -40.8% | 45,000,000 | -50.0% | 6.61% | +32.3% | |
| BBIO | Sell | BRIDGEBIO PHARMA INC | $363,567,000 | -61.6% | 7,756,928 | -50.0% | 5.28% | -14.0% |
| SWTX | Sell | SPRINGWORKS THERAPEUTICS INC | $307,678,000 | -61.5% | 4,849,912 | -50.0% | 4.47% | -13.9% |
| IOVA | Sell | IOVANCE BIOTHERAPEUTICS INC | $283,337,000 | -50.3% | 11,489,772 | -47.6% | 4.12% | +11.1% |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $253,643,000 | -43.1% | 26,559,443 | -42.6% | 3.68% | +27.3% |
| LABP | Sell | LANDOS BIOPHARMA INC | $217,101,000 | -36.8% | 14,869,915 | -50.0% | 3.15% | +41.4% |
| HZNP | Sell | HORIZON THERAPEUTICS PUB L | $214,363,000 | -42.3% | 1,956,940 | -50.7% | 3.11% | +29.0% |
| Sell | COLLEGIUM PHARMACEUTICAL INCnote 2.625% 2/1 | $180,250,000 | -52.5% | 17,500,000 | -50.0% | 2.62% | +6.2% | |
| VBIV | Sell | VBI VACCINES INC CDA | $171,182,000 | -53.6% | 55,042,465 | -50.0% | 2.49% | +3.8% |
| CERE | Sell | CEREVEL THERAPEUTICS HLDNG I | $150,058,000 | -36.9% | 5,086,727 | -45.2% | 2.18% | +41.1% |
| Sell | NEVRO CORPnote 2.750% 4/0 | $126,234,000 | -59.6% | 9,000,000 | -50.0% | 1.83% | -9.7% | |
| ISEE | Sell | IVERIC BIO INC | $121,342,000 | +109.7% | 7,471,798 | -18.5% | 1.76% | +368.9% |
| GBT | Sell | GLOBAL BLOOD THERAPEUTICS IN | $112,300,000 | -61.4% | 4,407,399 | -46.9% | 1.63% | -13.7% |
| NVTA | Sell | INVITAE CORP | $111,551,000 | -65.7% | 3,923,741 | -59.3% | 1.62% | -23.3% |
| ZYME | Sell | ZYMEWORKS INC | $106,863,000 | -64.2% | 3,679,845 | -57.3% | 1.55% | -20.0% |
| CCCC | Sell | C4 THERAPEUTICS INC | $100,913,000 | -41.0% | 2,258,566 | -50.0% | 1.47% | +32.1% |
| OM | Sell | OUTSET MED INC | $98,417,000 | -58.8% | 1,990,633 | -58.3% | 1.43% | -7.7% |
| MGTX | Sell | MEIRAGTX HLDGS PLC | $91,578,000 | -57.5% | 6,948,277 | -50.0% | 1.33% | -4.9% |
| RAPT | Sell | RAPT THERAPEUTICS INC | $90,280,000 | -42.6% | 2,907,565 | -41.3% | 1.31% | +28.3% |
| ALDX | Sell | ALDEYRA THERAPEUTICS INC | $86,956,000 | -61.3% | 9,903,879 | -50.0% | 1.26% | -13.4% |
| CRNX | Sell | CRINETICS PHARMACEUTICALS IN | $83,432,000 | -44.2% | 3,963,517 | -50.0% | 1.21% | +24.9% |
| AVIR | Sell | ATEA PHARMACEUTICALS INC | $79,208,000 | -18.4% | 2,259,224 | -50.0% | 1.15% | +82.7% |
| RXDX | Sell | PROMETHEUS BIOSCIENCES INC | $78,576,000 | -51.7% | 3,314,032 | -50.0% | 1.14% | +7.9% |
| CHRS | Sell | COHERUS BIOSCIENCES INC | $76,805,000 | -40.9% | 4,779,387 | -49.1% | 1.12% | +32.2% |
| ALBO | Sell | ALBIREO PHARMA INC | $73,636,000 | -55.7% | 2,360,139 | -50.0% | 1.07% | -0.8% |
| RCKT | Sell | ROCKET PHARMACEUTICALS INC | $69,054,000 | -71.7% | 2,310,261 | -58.0% | 1.00% | -36.6% |
| New | PROCEPT BIOROBOTICS CORP | $63,214,000 | – | 1,656,990 | +100.0% | 0.92% | – | |
| RLAY | Sell | RELAY THERAPEUTICS INC | $61,266,000 | -58.5% | 1,943,097 | -51.9% | 0.89% | -7.2% |
| New | ICOSAVAX INC | $56,888,000 | – | 1,922,549 | +100.0% | 0.83% | – | |
| NAUT | Sell | NAUTILUS BIOTECHNOLOGY INC | $54,714,000 | -69.6% | 8,911,151 | -50.0% | 0.80% | -32.0% |
| KRON | Sell | KRONOS BIO INC | $50,747,000 | -58.1% | 2,421,142 | -52.1% | 0.74% | -6.2% |
| MORF | Sell | MORPHIC HLDG INC | $50,259,000 | -53.3% | 887,340 | -52.7% | 0.73% | +4.4% |
| Sell | COHERUS BIOSCIENCES INCnote 1.500% 4/1 | $49,365,000 | -46.4% | 4,500,000 | -50.0% | 0.72% | +19.9% | |
| TVTX | Sell | TRAVERE THERAPEUTICS INC | $47,665,000 | -11.5% | 1,965,555 | -46.7% | 0.69% | +97.7% |
| BEAM | Sell | BEAM THERAPEUTICS INC | $46,780,000 | -66.2% | 537,635 | -50.0% | 0.68% | -24.4% |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $46,325,000 | -70.7% | 483,007 | -70.3% | 0.67% | -34.4% |
| VRCA | Sell | VERRICA PHARMACEUTICALS INC | $45,130,000 | -44.7% | 3,610,412 | -50.0% | 0.66% | +23.8% |
| MGNX | Sell | MACROGENICS INC | $44,980,000 | -61.0% | 2,148,060 | -50.0% | 0.65% | -12.8% |
| KOD | Sell | KODIAK SCIENCES INC | $44,271,000 | -16.8% | 461,248 | -19.4% | 0.64% | +85.8% |
| ATNX | Sell | ATHENEX INC | $40,733,000 | -67.4% | 13,532,467 | -50.0% | 0.59% | -27.1% |
| VERU | Sell | VERU INC | $37,970,000 | -47.1% | 4,451,342 | -50.0% | 0.55% | +18.2% |
| QTNT | Sell | QUOTIENT LTD | $37,910,000 | -67.9% | 16,200,818 | -50.0% | 0.55% | -28.1% |
| RAIN | Sell | RAIN THERAPEUTICS INC | $37,954,000 | -51.9% | 2,537,019 | -50.0% | 0.55% | +7.6% |
| DBVT | Sell | DBV TECHNOLOGIES S Asponsored adr | $37,708,000 | -55.1% | 7,695,505 | -50.0% | 0.55% | +0.4% |
| INBX | Sell | INHIBRX INC | $37,357,000 | -25.2% | 1,121,490 | -38.2% | 0.54% | +67.6% |
| ESTA | Sell | ESTABLISHMENT LABS HLDGS INC | $36,186,000 | -70.4% | 505,541 | -63.9% | 0.53% | -33.8% |
| OMIC | Sell | SINGULAR GENOMICS SYSTEMS IN | $34,396,000 | -79.7% | 3,073,824 | -50.1% | 0.50% | -54.5% |
| LPTX | Sell | LEAP THERAPEUTICS INC | $33,990,000 | +22.3% | 8,476,496 | -50.0% | 0.49% | +172.9% |
| TMCI | Sell | TREACE MED CONCEPTS INC | $33,245,000 | -57.0% | 1,235,886 | -50.0% | 0.48% | -3.8% |
| CMAX | Sell | CAREMAX INC | $32,699,000 | -61.8% | 3,385,000 | -49.0% | 0.48% | -14.6% |
| IMTX | Sell | IMMATICS N.V | $32,500,000 | -44.0% | 2,500,000 | -50.0% | 0.47% | +25.2% |
| ATHA | Sell | ATHIRA PHARMA INC | $32,135,000 | -54.2% | 3,425,916 | -50.0% | 0.47% | +2.4% |
| SLDB | Sell | SOLID BIOSCIENCES INC | $32,056,000 | -67.3% | 13,412,552 | -50.0% | 0.47% | -27.0% |
| XENE | Sell | XENON PHARMACEUTICALS INC | $30,897,000 | -50.6% | 2,022,051 | -39.8% | 0.45% | +10.6% |
| NVRO | Sell | NEVRO CORP | $30,256,000 | -88.9% | 259,972 | -84.1% | 0.44% | -75.1% |
| NUVB | Sell | NUVATION BIO INC | $30,228,000 | -46.6% | 3,041,004 | -50.0% | 0.44% | +19.3% |
| HCAT | Sell | HEALTH CATALYST INC | $29,456,000 | -53.1% | 589,004 | -48.0% | 0.43% | +4.9% |
| LYRA | Sell | LYRA THERAPEUTICS INC | $29,403,000 | -43.2% | 3,222,560 | -50.0% | 0.43% | +27.1% |
| TARS | Sell | TARSUS PHARMACEUTICALS INC | $27,937,000 | -62.8% | 1,296,416 | -50.0% | 0.41% | -16.8% |
| COGT | Sell | COGENT BIOSCIENCES INC | $26,817,000 | -48.2% | 3,188,750 | -50.0% | 0.39% | +16.1% |
| UTHR | Sell | UNITED THERAPEUTICS CORP DEL | $26,155,000 | -88.2% | 141,700 | -88.5% | 0.38% | -73.6% |
| New | SOMALOGIC INC | $25,400,000 | – | 2,050,000 | +100.0% | 0.37% | – | |
| BCAB | Sell | BIOATLA INC | $25,025,000 | -56.9% | 850,026 | -38.0% | 0.36% | -3.4% |
| VRDN | Sell | VIRIDIAN THERAPEUTICS INC | $23,408,000 | -19.5% | 1,423,000 | -10.4% | 0.34% | +79.9% |
| RNA | Sell | AVIDITY BIOSCIENCES INC | $21,818,000 | -59.1% | 885,818 | -59.0% | 0.32% | -8.4% |
| CLDX | Sell | CELLDEX THERAPEUTICS INC NEW | $21,251,000 | -57.2% | 393,613 | -73.5% | 0.31% | -4.3% |
| APLS | Sell | APELLIS PHARMACEUTICALS INC | $20,270,000 | -75.7% | 615,000 | -53.5% | 0.29% | -45.9% |
| New | SEMA4 HOLDINGS CORP | $18,975,000 | – | 2,500,000 | +100.0% | 0.28% | – | |
| HRMY | Sell | HARMONY BIOSCIENCES HLDGS IN | $18,833,000 | -32.1% | 491,332 | -50.0% | 0.27% | +52.2% |
| New | CUE HEALTH INC | $18,667,000 | – | 1,580,607 | +100.0% | 0.27% | – | |
| New | IMMUNEERING CORP | $18,082,000 | – | 681,051 | +100.0% | 0.26% | – | |
| NTRA | New | NATERA INC | $17,830,000 | – | 160,000 | +100.0% | 0.26% | – |
| New | ASTRIA THERAPEUTICS INC | $17,323,000 | – | 1,959,652 | +100.0% | 0.25% | – | |
| New | TYRA BIOSCIENCES INC | $17,370,000 | – | 987,500 | +100.0% | 0.25% | – | |
| New | ABSCI CORPORATION | $17,175,000 | – | 1,476,776 | +100.0% | 0.25% | – | |
| New | NUVALENT INC | $16,913,000 | – | 750,000 | +100.0% | 0.25% | – | |
| VRNA | Sell | VERONA PHARMA PLCsponsored ads | $15,831,000 | -58.1% | 2,888,889 | -50.0% | 0.23% | -6.1% |
| CCXI | New | CHEMOCENTRYX INCcall | $15,786,000 | – | 923,200 | +100.0% | 0.23% | – |
| AGRX | Sell | AGILE THERAPEUTICS INC | $15,301,000 | -63.9% | 15,919,925 | -50.0% | 0.22% | -19.3% |
| ADMA | Sell | ADMA BIOLOGICS INC | $14,986,000 | -71.8% | 13,262,375 | -60.0% | 0.22% | -36.8% |
| HCAQ | Sell | HEALTHCOR CATALIO ACQU CORP | $14,850,000 | -49.7% | 1,500,000 | -50.0% | 0.22% | +12.5% |
| IMCR | Sell | IMMUNOCORE HLDGS PLCads | $14,828,000 | -52.5% | 400,000 | -50.0% | 0.22% | +5.9% |
| GRPH | Sell | GRAPHITE BIO INC | $14,343,000 | -73.3% | 875,093 | -50.0% | 0.21% | -40.4% |
| ACRS | Sell | ACLARIS THERAPEUTICS INC | $14,062,000 | -52.9% | 781,236 | -54.0% | 0.20% | +5.2% |
| BIIB | New | BIOGEN INC | $13,753,000 | – | 48,600 | +100.0% | 0.20% | – |
| VTRS | Sell | VIATRIS INC | $13,610,000 | -52.6% | 1,004,419 | -50.0% | 0.20% | +6.5% |
| DAWN | Sell | DAY ONE BIOPHARMACEUTICALS I | $13,195,000 | -61.7% | 556,047 | -63.2% | 0.19% | -14.3% |
| CMLTU | Sell | CM LIFE SCIENCES III INCunit 04/30/2028 | $12,813,000 | -53.2% | 1,250,000 | -50.0% | 0.19% | +4.5% |
| Sell | NANOSTRING TECHNOLOGIES INCnote 2.625% 3/0 | $12,799,000 | -60.5% | 1,000,000 | -50.0% | 0.19% | -11.4% | |
| PODD | New | INSULET CORP | $12,654,000 | – | 44,522 | +100.0% | 0.18% | – |
| NBTX | Sell | NANOBIOTIX SAsponsored ads | $12,039,000 | -58.8% | 1,059,800 | -50.0% | 0.18% | -7.9% |
| ADPT | Sell | ADAPTIVE BIOTECHNOLOGIES COR | $11,992,000 | -58.4% | 352,804 | -50.0% | 0.17% | -7.0% |
| ACCD | Sell | ACCOLADE INC | $11,798,000 | -55.8% | 279,774 | -43.1% | 0.17% | -1.2% |
| ZY | Sell | ZYMERGEN INC | $11,633,000 | -91.1% | 883,332 | -73.0% | 0.17% | -80.1% |
| CLOV | Sell | CLOVER HEALTH INVESTMENTS CO | $11,085,000 | -72.3% | 1,500,000 | -50.0% | 0.16% | -38.1% |
| ONEM | Sell | 1LIFE HEALTHCARE INC | $10,780,000 | -68.4% | 532,350 | -48.4% | 0.16% | -29.3% |
| KYMR | New | KYMERA THERAPEUTICS INC | $10,573,000 | – | 180,000 | +100.0% | 0.15% | – |
| ONCR | Sell | ONCORUS INC | $10,272,000 | -74.6% | 1,099,810 | -62.4% | 0.15% | -43.1% |
| FDMT | Sell | 4D MOLECULAR THERAPEUTICS IN | $10,121,000 | -44.0% | 375,256 | -50.0% | 0.15% | +25.6% |
| SMIHU | Sell | SUMMIT HEALTHCRE ACQUISTN COunit 06/03/2026 | $10,050,000 | -49.8% | 1,000,000 | -50.0% | 0.15% | +12.3% |
| BLSA | Sell | BCLS ACQUISITION CORP | $9,960,000 | -52.7% | 1,000,000 | -50.0% | 0.14% | +5.8% |
| FUSN | Sell | FUSION PHARMACEUTICALS INC | $9,936,000 | -65.4% | 1,254,607 | -64.7% | 0.14% | -22.6% |
| RACB | Sell | RESEARCH ALLIANCE CORP II | $9,850,000 | -51.4% | 1,000,000 | -50.0% | 0.14% | +8.3% |
| PNT | New | POINT BIOPHARMA GLOBAL INC | $9,557,000 | – | 1,242,879 | +100.0% | 0.14% | – |
| CCXI | New | CHEMOCENTRYX INC | $9,405,000 | – | 550,000 | +100.0% | 0.14% | – |
| PMVP | Sell | PMV PHARMACEUTICALS INC | $8,991,000 | -82.4% | 301,714 | -79.8% | 0.13% | -60.4% |
| New | SIGHT SCIENCES INC | $8,853,000 | – | 390,000 | +100.0% | 0.13% | – | |
| FULC | Sell | FULCRUM THERAPEUTICS INC | $8,297,000 | +34.6% | 294,118 | -50.0% | 0.12% | +202.5% |
| PRTA | Sell | PROTHENA CORP PLC | $7,123,000 | -30.7% | 100,000 | -50.0% | 0.10% | +53.7% |
| CNCE | Sell | CONCERT PHARMACEUTICALS INC | $7,033,000 | -61.3% | 2,150,641 | -50.0% | 0.10% | -13.6% |
| New | RAPID MICRO BIOSYSTEMS INC | $6,465,000 | – | 350,000 | +100.0% | 0.09% | – | |
| SAVA | New | CASSAVA SCIENCES INCput | $6,208,000 | – | 100,000 | +100.0% | 0.09% | – |
| NEPT | Sell | NEPTUNE WELLNESS SOLUTIONS I | $6,080,000 | -79.8% | 10,055,521 | -60.9% | 0.09% | -54.9% |
| PRVB | Sell | PROVENTION BIO INC | $6,070,000 | -62.0% | 948,481 | -50.0% | 0.09% | -15.4% |
| TSHA | Sell | TAYSHA GENE THERAPIES INC | $5,967,000 | -56.1% | 320,440 | -50.0% | 0.09% | -1.1% |
| ACHL | Sell | ACHILLES THERAPEUTICS PLCsponsored ads | $5,884,000 | -60.2% | 755,375 | -50.0% | 0.08% | -11.5% |
| PSTX | Sell | POSEIDA THERAPEUTICS INC | $5,743,000 | -63.6% | 787,745 | -50.0% | 0.08% | -19.4% |
| ATEC | Sell | ALPHATEC HLDGS INC | $5,252,000 | -90.5% | 430,900 | -88.0% | 0.08% | -78.8% |
| New | DA32 LIFE SCNCE TEC ACQSTN C | $4,915,000 | – | 500,000 | +100.0% | 0.07% | – | |
| DNAY | Sell | CODEX DNA INC | $4,730,000 | -74.7% | 425,000 | -50.0% | 0.07% | -43.0% |
| HSAQ | Sell | HEALTH SCIENCES ACQ CORP 2 | $4,451,000 | -51.5% | 450,000 | -50.0% | 0.06% | +8.3% |
| Sell | DARIOHEALTH CORP | $4,475,000 | -68.0% | 327,869 | -50.0% | 0.06% | -28.6% | |
| RGNX | Sell | REGENXBIO INC | $3,743,000 | -46.1% | 89,283 | -50.0% | 0.05% | +20.0% |
| New | SURROZEN INC | $3,540,000 | – | 500,000 | +100.0% | 0.05% | – | |
| VYNE | Sell | VYNE THERAPEUTICS INC | $3,239,000 | -92.0% | 2,330,471 | -79.8% | 0.05% | -82.1% |
| LSAQ | Sell | LIFESCI ACQUISITION II CORP | $2,940,000 | -51.0% | 300,000 | -50.0% | 0.04% | +10.3% |
| TARA | Sell | PROTARA THERAPEUTICS INC | $2,918,000 | -64.5% | 421,641 | -50.0% | 0.04% | -20.8% |
| AXSM | Sell | AXSOME THERAPEUTICS INC | $2,651,000 | -96.5% | 80,420 | -92.7% | 0.04% | -92.0% |
| New | IMAGO BIOSCIENCES INC | $2,504,000 | – | 125,000 | +100.0% | 0.04% | – | |
| FREQ | Sell | FREQUENCY THERAPEUTICS INC | $1,569,000 | -64.6% | 222,222 | -50.0% | 0.02% | -20.7% |
| RACE | Sell | FERRARI N V | $1,297,000 | -49.3% | 6,200 | -50.0% | 0.02% | +11.8% |
| MOTS | Sell | MOTUS GI HLDGS INC | $1,242,000 | -66.8% | 1,800,542 | -50.0% | 0.02% | -25.0% |
| New | ROCKLEY PHOTONICS HOLDINGS L*w exp 08/11/202 | $1,195,000 | – | 500,000 | +100.0% | 0.02% | – | |
| EIGR | Sell | EIGER BIOPHARMACEUTICALS INC | $934,000 | -60.8% | 139,890 | -50.0% | 0.01% | -6.7% |
| BFLYWS | Sell | BUTTERFLY NETWORK INC*w exp 02/12/202 | $642,000 | -71.5% | 233,333 | -50.0% | 0.01% | -40.0% |
| PHVS | Sell | PHARVARIS N V | $479,000 | -52.4% | 27,000 | -50.0% | 0.01% | 0.0% |
| New | SOMALOGIC INC*w exp 03/01/202 | $380,000 | – | 110,000 | +100.0% | 0.01% | – | |
| New | SURROZEN INC*w exp 08/01/203 | $190,000 | – | 166,666 | +100.0% | 0.00% | – | |
| CMAXW | Sell | CAREMAX INC*w exp 06/08/202 | $170,000 | -70.0% | 60,000 | -50.0% | 0.00% | -50.0% |
| RAPT | Exit | RAPT THERAPEUTICS INCput | $0 | – | -90,000 | -100.0% | -0.00% | – |
| TCRR | Exit | TCR2 THERAPEUTICS INC | $0 | – | -61,506 | -100.0% | -0.01% | – |
| TKNO | Exit | ALPHA TEKNOVA INC | $0 | – | -60,000 | -100.0% | -0.01% | – |
| PLXP | Exit | PLX PHARMA INC | $0 | – | -114,918 | -100.0% | -0.01% | – |
| SCPEWS | Exit | SC HEALTH CORP*w exp 99/99/999 | $0 | – | -1,000,000 | -100.0% | -0.01% | – |
| SGTX | Exit | SIGILON THERAPEUTICS INC | $0 | – | -250,000 | -100.0% | -0.02% | – |
| SRRA | Exit | SIERRA ONCOLOGY INC | $0 | – | -133,310 | -100.0% | -0.02% | – |
| CEREW | Exit | CEREVEL THERAPEUTICS HLDNG I*w exp 06/09/202 | $0 | – | -266,132 | -100.0% | -0.02% | – |
| GRTX | Exit | GALERA THERAPEUTICS INC | $0 | – | -509,328 | -100.0% | -0.03% | – |
| CMLF | Exit | CM LIFE SCIENCES INC | $0 | – | -454,000 | -100.0% | -0.04% | – |
| AMWL | Exit | AMERICAN WELL CORPcl a | $0 | – | -580,000 | -100.0% | -0.05% | – |
| MRUS | Exit | MERUS NV | $0 | – | -350,000 | -100.0% | -0.05% | – |
| LGVU | Exit | LONGVIEW ACQUISITION CORP IIunit 99/99/9999 | $0 | – | -1,000,000 | -100.0% | -0.06% | – |
| CHFWU | Exit | CONSONANCE HFW ACQUISITION Cunit 99/99/9999 | $0 | – | -1,000,000 | -100.0% | -0.07% | – |
| MREO | Exit | MEREO BIOPHARMA GROUP PLCads | $0 | – | -3,392,136 | -100.0% | -0.07% | – |
| BCTG | Exit | BCTG ACQUISITION CORP | $0 | – | -1,000,000 | -100.0% | -0.07% | – |
| AKYA | Exit | AKOYA BIOSCIENCES INC | $0 | – | -600,000 | -100.0% | -0.08% | – |
| PRVA | Exit | PRIVIA HEALTH GROUP INC | $0 | – | -270,000 | -100.0% | -0.08% | – |
| SILK | Exit | SILK RD MED INC | $0 | – | -294,266 | -100.0% | -0.09% | – |
| RACA | Exit | THERAPEUTICS ACQUISITION COR | $0 | – | -1,500,000 | -100.0% | -0.10% | – |
| CTMX | Exit | CYTOMX THERAPEUTICS INC | $0 | – | -3,281,914 | -100.0% | -0.14% | – |
| CVRX | Exit | CVRX INC | $0 | – | -880,000 | -100.0% | -0.16% | – |
| Exit | CATABASIS PHARMACEUTICALS IN | $0 | – | -15,374,370 | -100.0% | -0.21% | – | |
| TDOC | Exit | TELADOC HEALTH INCcall | $0 | – | -200,000 | -100.0% | -0.22% | – |
| CMIIU | Exit | CM LIFE SCIENCES II INCunit 02/25/2028 | $0 | – | -2,500,000 | -100.0% | -0.22% | – |
| STOK | Exit | STOKE THERAPEUTICS INC | $0 | – | -1,343,956 | -100.0% | -0.29% | – |
| FBRX | Exit | FORTE BIOSCIENCES INC | $0 | – | -1,370,000 | -100.0% | -0.30% | – |
| COLL | Exit | COLLEGIUM PHARMACEUTICAL INC | $0 | – | -1,956,554 | -100.0% | -0.30% | – |
| ARWR | Exit | ARROWHEAD PHARMACEUTICALS IN | $0 | – | -630,282 | -100.0% | -0.34% | – |
| RGEN | Exit | REPLIGEN CORP | $0 | – | -265,000 | -100.0% | -0.34% | – |
| XLRN | Exit | ACCELERON PHARMA INC | $0 | – | -453,520 | -100.0% | -0.37% | – |
| NARI | Exit | INARI MED INC | $0 | – | -620,874 | -100.0% | -0.38% | – |
| EXAS | Exit | EXACT SCIENCES CORP | $0 | – | -467,046 | -100.0% | -0.38% | – |
| DRNA | Exit | DICERNA PHARMACEUTICALS INC | $0 | – | -1,600,000 | -100.0% | -0.39% | – |
| MDT | Exit | MEDTRONIC PLC | $0 | – | -900,000 | -100.0% | -0.73% | – |
| KDMN | Exit | KADMON HLDGS INC | $0 | – | -31,422,668 | -100.0% | -0.79% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2021-12-03
About Perceptive Advisors
Perceptive Advisors is a New York-based hedge fund that specializes in healthcare investments. The company was founded in 1999 by Joseph Edelman, who serves as the CEO and Chief Investment Officer. Since its inception, Perceptive Advisors has become one of the most successful healthcare-focused hedge funds in the world, with over $5 billion in assets under management.
The company's investment strategy is based on a deep understanding of the healthcare industry and a focus on identifying promising companies with innovative products and technologies. Perceptive Advisors invests in a wide range of healthcare sectors, including biotechnology, pharmaceuticals, medical devices, and healthcare services.
One of the key factors behind Perceptive Advisors' success is its team of experienced professionals. In addition to Joseph Edelman, the company's leadership team includes Adam Stone, the COO, and Jeremy Goldberg, the Chief Scientific Officer. The team also includes a group of highly skilled analysts and researchers who are experts in their respective fields.
Perceptive Advisors has a strong track record of generating high returns for its investors. However, it is important to note that investing in hedge funds carries significant risks, and investors should carefully consider their investment objectives and risk tolerance before investing. As with any investment, it is important to conduct thorough research and seek the advice of a qualified financial advisor before making any investment decisions.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES SHARES | 42 | Q3 2023 | 15.7% |
| AMICUS THERAPEUTICS SHARES | 39 | Q3 2023 | 14.0% |
| ALDEYRA THERAPEUTICS SHARES | 35 | Q3 2023 | 3.3% |
| QUOTIENT TECHNOLOGY INC | 34 | Q3 2022 | 2.7% |
| GLOBAL BLOOD THERAPEUTICS SHARES | 29 | Q3 2022 | 9.3% |
| ADMA BIOLOGICS SHARES | 29 | Q3 2023 | 1.4% |
| RETROPHIN SHARES | 28 | Q3 2020 | 5.5% |
| DBV TECHNOLOGIES SA-SPON ADR | 28 | Q3 2021 | 1.8% |
| VBI VACCINES SHARES | 27 | Q1 2023 | 2.8% |
| IOVANCE BIOTHERAPEUTICS INC | 26 | Q3 2023 | 9.1% |
View Perceptive Advisors's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| CHEMBIO DIAGNOSTICS, INC.Sold out | May 04, 2023 | 0 | 0.0% |
| VBI Vaccines Inc/BC | April 07, 2023 | 43,509,553 | 16.7% |
| Landos Biopharma, Inc. | March 30, 2023 | 14,869,915 | 47.7% |
| REATA PHARMACEUTICALS INC | March 07, 2023 | 2,083,799 | 6.5% |
| AGILE THERAPEUTICS INCSold out | February 14, 2023 | 0 | 0.0% |
| ALBIREO PHARMA, INC. | February 14, 2023 | 1,757,160 | 8.5% |
| BELLUS Health Inc. | February 14, 2023 | 8,891,027 | 7.1% |
| CinCor Pharma, Inc. | February 14, 2023 | 2,576,325 | 5.9% |
| Coherus BioSciences, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| CONCERT PHARMACEUTICALS, INC. | February 14, 2023 | 1,800,000 | 3.6% |
View Perceptive Advisors's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-17 |
| SC 13D/A | 2024-04-17 |
| 4 | 2024-04-15 |
| SC 13G/A | 2024-04-15 |
| SC 13G | 2024-04-15 |
| SC 13D/A | 2024-04-10 |
| 4 | 2024-04-08 |
| 4 | 2024-04-03 |
| SC 13D/A | 2024-04-03 |
| SC 13D | 2024-03-20 |
View Perceptive Advisors's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.